Author: Bella Hayes

LONDON – ASA International Group plc (LSE: ASAI), a prominent global microfinance institution, has disclosed updated remuneration details for its directors. The announcement, made on January 08, 2025, outlines the compensation arrangements for the company’s top executives as per the Directors’ Remuneration Policy, which shareholders approved at the Annual General Meeting on June 15, 2023. Rob Keijsers, serving as the Interim Chief Executive Officer, receives a base salary of 234,640.50 annually, with an additional EUR 92,043 allowance for his interim role. His remuneration package also includes participation in the Long-Term Incentive Plan (LTIP) and a pension allowance of 10% of…

LONDON – ChallengerX plc (AQUIS: CXS) has announced the issuance of a Convertible Loan Note (CLN) to raise £120,000. The funds from this financial instrument are earmarked for due diligence on potential acquisitions and efforts to reinstate the trading of the company’s ordinary shares on the Aquis Stock Exchange. The CLN will carry an annual interest rate of 5%, with the first interest payment scheduled for June 30, 2025, and subsequent payments every six months. Under the terms of the loan, the amount raised will automatically convert into 120 million ordinary shares of the company at 0.1 pence each if…

VANCOUVER, BRITISH COLUMBIA – BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0), known for its proprietary Botanical Synthesis technology, has reported a year of significant transformation and growth, according to a shareholder letter from CEO Ilan Sobel. InvestingPro data reveals impressive revenue growth of 111.68% over the last twelve months, with analysts projecting continued sales growth this year. The company launched its CDMO Services division, partnered with Tate & Lyle, and doubled its core VINIA® capsule business in 2024. Additionally, BioHarvest successfully introduced VINIA Inside products, targeting a broader consumer market. The CDMO Services division, unveiled in early March…

Handling over 1 million 911 calls annually, San Francisco’s DEM will leverage NICE’s automatedsolutions to bolster services to citizens, first responders and partner agencies HOBOKEN, N.J.–(BUSINESS WIRE)–NICE (: NICE) today announced that the San Francisco Department of Emergency Management (DEM) has chosen NICE Inform Elite, one of the solutions in NICE’s Evidencentral platform, to bolster services to residents, first responders and partner agencies. The City’s dispatch center is one of the top 25 busiest in the U.S., handling over one million emergency calls annually. San Francisco DEM, a NICE customer since 2006, will be upgrading to NICE’s advanced capabilities. NICE…

HACKENSACK, NJ – Champions Oncology , Inc. (NASDAQ:), a research organization specializing in oncology with a focus on technology-enabled testing services, has announced the expansion of its bioanalytical services with new technology and leadership. The company has integrated several Cytek Aurora flow cytometers into its portfolio and appointed Troy Tremaine, MBA, as the new head of Bioanalytical Commercial Strategy. The integration of Cytek Aurora technology is set to enhance the company’s existing spectral and conventional flow cytometry capabilities, allowing for more complex spectral analysis. This strategic move is expected to better serve Champions Oncology’s clients by offering more in-depth analytical…

BOSTON – Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company with a market capitalization of $2.28 billion, announced the appointment of Stephen Kanes MD PhD as its new Chief Medical (TASE:) Officer. Dr. Kanes, a neuropsychiatrist with over 30 years of experience in neuroscience, clinical psychiatry, and drug development, joins Centessa as it advances its portfolio of orexin receptor 2 (OX2R) agonists, with multiple clinical milestones expected this year. According to InvestingPro data, the company maintains a strong financial position with liquid assets exceeding short-term obligations by a significant margin, as reflected in its impressive current ratio of 21.52. Dr.…

RAHWAY, N.J. – Merck (NS:) & Co., Inc. (NYSE: MRK), a global healthcare company, announced that the National Medical (TASE:) Products Administration (NMPA) of China has approved the use of GARDASIL® for males aged 9 to 26. This marks the vaccine as the first in China to prevent certain human papillomavirus (HPV)-related cancers and diseases in males. The vaccine is now authorized to prevent anal cancers caused by HPV Types 16 and 18, genital warts due to HPV Types 6 and 11, and various precancerous or dysplastic lesions associated with HPV Types 6, 11, 16, and 18. This expansion of…

Investing.com — Shares of Flutter Entertainment (NYSE:) (LON:) traded lower on Wednesday after the company downgraded its U.S. revenue and profit forecasts for 2024, citing an unprecedented string of favorable results for NFL bettors. The company, which owns FanDuel, reported that the current NFL season has been the most customer-friendly in nearly two decades, with a high rate of favorites winning games. “Any share price weakness following a short-term margin dip in this structurally improving margin environment would be a buying opportunity, in our view,” said analysts at Jefferies in a note. The online sports betting and iGaming company in…

Investing.com — Barclays (LON:) analysts in a note dated Wednesday have initiated coverage on Levi Strauss & Co (NYSE:). with an “overweight” rating, citing a combination of accelerating organic sales growth, operational improvements, and an attractive valuation as the basis for their outlook.  As per Barclays, the company is positioned to see momentum in sales driven by recovery in the wholesale segment, expansion in women’s apparel and tops, and the continued evolution in denim styles.  These trends are expected to contribute to Levi’s growth trajectory through 2025. The analysts noted that Levi Strauss is addressing key operational challenges and opportunities,…

FRANKFURT – Deutsche Lufthansa (ETR:) Aktiengesellschaft has initiated a pre-stabilization period as of today, with J.P. Morgan SE acting as the stabilization coordinator. The airline is offering a new series of subordinated obligations, which are expected to be admitted to the Official List of the Luxembourg Stock Exchange and to be traded on its regulated market. The securities are described as 30NC6 subordinated obligations, ranking pari passu among themselves, senior to all junior obligations but junior to senior obligations. The offer price and other terms have yet to be confirmed, with the aggregate nominal amount described as benchmark. The stabilization…